Company Focus

Takeda

Latest Takeda News

Takeda revenue reduced by Vyvanse competition
Pharmaceutical
Japanese drugmaker Takeda has announced earnings results for the first quarter of Japan’s fiscal year 2025, ending June 30.   30 July 2025


Insights

Company Spotlight

Latest News & Features of interest to Takeda

Latest In Brief for Takeda

Pharmaceutical
Ireland-based biopharma Jazz Pharmaceuticals has been called out for a couple of indiscretions by The Prescription Medicines Code of Practice Authority (PMCPA), which was established by the Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry.   11 July 2025

Latest Relevant Ones To Watch News

US specialty pharma business SERB Pharmaceuticals is acquiring Y-mAbs Therapeutics in a $412 million all-cash deal that brings the pediatric cancer drug Danyelza (naxitamab-gqgk) into its rare oncology portfolio.   6 August 2025

More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search